Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by Accountprinceon Sep 28, 2023 4:07pm
154 Views
Post# 35660241

RE:RE:RE:Another amazing day in

RE:RE:RE:Another amazing day in BSW - the rumors you started about selling and leaving - "Good riddance" and "won't be looking back" - were greatly exaggerated - by you.  Sadly it looks like you just won't leave.  Your verbal flatulence seems to continue on incessantly.  You did prove one thing by not leaving - your word is not worth anything and can't be trusted.

BTW - things are going very well.  Baxter recently doubled down on their investment along with Pinnacle LP by doing the oversold and increased amount of convertible debt financing.  If that isn't a ringing endorsement I don't know what is.  The Tigris trial is progressing and marching towards the interim point of 90 enrolled - just 18 left at last count with management continuing to state they will get to 90 by the end of 2023.  Results are said to be exceeding expectations.  Baxter is set to use PMX on day 1 of FDA approval and the FDA has given PMX the breakthrough designation.  Management has highlighted a US$247 million EBITDA potential at only 40% market penetration.  Conservatiive valuations of $4 to $8 per share abound.  To be reaped by those intelligent enough to recognize value.

Yet you're here trumpeting selling your position at $0.45 a share as brilliant?  While pushing copper mining in Namibia?  And pushing uranium?  Get the big picture of what's going on if you can.


<< Previous
Bullboard Posts
Next >>